Navigation Links
Perrigo Reports Record Third Quarter
Date:5/7/2009

$63,014 $54,919 $182,859 $123,775 ======= ======= ======== ======== Adjusted operating income % 15.0% 14.7% 14.8% 12.9% Unallocated Reported operating loss $(5,433) $(10,420) $(14,021) $(16,174) Write-off of in- process R&D - Diba acquisition - - 279 - Write-off of in- process R&D - Galpharm acquisition - 2,786 - 2,786 ----- ----- ----- ----- Adjusted operating loss $(5,433) $(7,634) $(13,742) $(13,388) ======= ======= ======== ======== *All information based on continuing operations. Table III 2009 GUIDANCE RECONCILIATION OF NON-GAAP MEASURES (unaudited) Full Year Fiscal 2009 Guidance -------------------- Reported earnings per share from continuing operations range $1.60 - $1.70 Loss on asset exchange $0.007 Charges associated with inventory step- ups $0.021 Fixed asset impairment $0.011 Write-off of in- process R&D $0.002 Investment impairment $0.161 ------ Adjusted earnings per share from continuing operations range $1.80 - $1.90 ===============
'/>"/>
SOURCE Perrigo Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Related medicine news :

1. Perrigo Vice Chair Mori Arkin To Retire After 30 Years of Service
2. Perrigo Company to Host Analyst Meeting on September 18, 2007
3. Perrigo Company Announces FDA Approval for Ciclopirox Topical Solution
4. Perrigo Company Announces FDA Approval for Ciclopirox Topical Solution
5. Perrigo Confirms Filing for Generic Version of Mucinex(R) and Announcement of Lawsuit by Adams Respiratory
6. Perrigo Company Will Release First Quarter Fiscal 2008 Results on November 1, 2007
7. Perrigo Company Announces Dividend Increase
8. Perrigo Announces that Dexcels Settlement with AstraZeneca Allows OTC Omeprazole Launch Following Final FDA Approval
9. Perrigo Company to Present at The 26th Annual JPMorgan Healthcare Conference
10. Perrigo Acquires UK OTC Store Brand Supplier
11. Perrigo Company Authorizes Continuation of Share Repurchase Program and Announces Quarterly Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... MONDAY, Sept. 15, 2014 (HealthDay News) -- U.S. heart ... an electrocardiogram (ECG) when evaluating young people for underlying ... The American Heart Association and the American College ... more detailed personal and family medical history along with ... genetic or congenital (existing from birth) risks for sudden ...
(Date:9/15/2014)... approximately one out of every 40 individuals in the United ... muscular atrophy (SMA), a neurodegenerative disease that causes muscles to ... have made a recent breakthrough with the development of a ... of the disease. In April, a patent was filed for ... lab is using to fight SMA is to ,repress the ...
(Date:9/15/2014)... Worth, FL (PRWEB) September 15, 2014 ... policy away from putting low-level offenders in jail and ... Treatment Group sees this shift as a positive change. ... of prescription drug and heroin abuse. According to an ... both parties are calling for a shift away from ...
(Date:9/15/2014)... September 15, 2014 Florida is now one ... anyone who refuses a breath test could be forced to ... the new policy will prevent more people from drinking and ... among the highest rate of breathalyzer refusal. The new law ... According to CBS Miami , the new Florida law ...
(Date:9/15/2014)... HealthDay Reporter MONDAY, Sept. 15, 2014 ... responsible for sending thousands of young children to the hospital ... year between 2007 and 2011, about 9,500 U.S. children younger ... family members, medication, according to the U.S. Centers for Disease ... just 1 or 2 years old," said Dr. Daniel Budnitz, ...
Breaking Medicine News(10 mins):Health News:Heart Docs Don't Recommend Routine ECGs for Young Athletes 2Health News:Heart Docs Don't Recommend Routine ECGs for Young Athletes 3Health News:Researcher develops and proves effectiveness of new drug for spinal muscular atrophy 2Health News:White House Shifts Policy on Drugs 2Health News:New DUI Law Makes Blood Tests Mandatory 2Health News:Small Number of Drugs Behind Kids' Accidental Poisonings: CDC 2Health News:Small Number of Drugs Behind Kids' Accidental Poisonings: CDC 3
... DIEGO, Dec. 3 SGX Pharmaceuticals, Inc.,(Nasdaq: ... an investigational new,drug (IND) application to the U.S. ... an internally developed, orally-bioavailable, small,molecule inhibitor of the ... Phase I clinical trials of SGX523 for solid ...
... Germany and OXFORD, England, December 3 /PRNewswire-FirstCall/,-- Evotec ... it has,completed the sale of its Chemical Development ... GBP 31.5 million (approx. EUR 44 million),effective November ... focus even more on its strategy to,become an ...
... donation" appeal at last,night,s Hutch Holiday Gala helped push ... Fred Hutchinson Cancer Research Center., The annual black-tie ... event took place from 5 p.m. until midnight at ... portion of the live auction during which every,dollar donated ...
... at bay, expert says , SUNDAY, Dec. 2 (HealthDay News) -- ... all too easy to pack on extra pounds when joining family ... help you avoid weight gain, says Jennifer Ebelhar, an assistant professor ... to indulge in a little of your favorite holiday treats. But ...
... hours, work at night, struggle to remain awake at work, ... drowsy driving episode, according to a study published in the ... authored by Linda D. Scott, PhD, of Grand Valley State ... collected from 895 full-time hospital staff nurses, who completed logbooks ...
... 1 issue of the journal SLEEP is the first to ... duration are associated with an elevated risk of mortality by ... Jane E. Ferrie, PhD, of the University College London Medical ... and 55 years of age. Baseline screening (Phase 1), ...
Cached Medicine News:Health News:SGX Pharmaceuticals Submits Investigational New Drug Application for SGX523, a Highly Potent, Selective, Orally Bioavailable cMET Inhibitor 2Health News:SGX Pharmaceuticals Submits Investigational New Drug Application for SGX523, a Highly Potent, Selective, Orally Bioavailable cMET Inhibitor 3Health News:Evotec Completes Divesture of Chemical Development Business to Aptuit 2Health News:Evotec Completes Divesture of Chemical Development Business to Aptuit 3Health News:Evotec Completes Divesture of Chemical Development Business to Aptuit 4Health News:32nd Annual Hutch Holiday Gala Raises Millions for Cancer Research 2Health News:32nd Annual Hutch Holiday Gala Raises Millions for Cancer Research 3Health News:Holidays Don't Have to Leave You Heavier 2Health News:Nurses working extended shifts, are tired at work and sleep little likely to drive drowsy 2Health News:Nurses working extended shifts, are tired at work and sleep little likely to drive drowsy 3Health News:Nurses working extended shifts, are tired at work and sleep little likely to drive drowsy 4Health News:Short, long sleep duration associated with increased mortality 2
(Date:9/15/2014)... -- Research and Markets has announced the addition ... Tests, 9th Edition" report to their offering. ... testing market and all of its segments, providing customers with ... For Business Planning. This is the ninth edition ... 2013 and early 2014. New entrants, new technologies have entered ...
(Date:9/15/2014)... 15, 2014 Biomerics LLC, a leading ... market, announced its merger with Access Point Technologies ... new division was formed to provide next generation ... the structure heart, interventional radiology, interventional cardiology, and ... Catheter will be led by Steve Berhow ...
(Date:9/15/2014)... 15, 2014  MedExpress Urgent Care, a national leader in ... flu shots for ages four and up at each of ... get their flu shot early. According to ... of June, making late summer and early fall an ideal ... Vice President of Provider and Clinical Quality, Thomas Pangburn ...
Breaking Medicine Technology:The Worldwide Market for In Vitro Diagnostic Tests, 9th Edition 2The Worldwide Market for In Vitro Diagnostic Tests, 9th Edition 3Biomerics and Access Point Technologies OEM Announce Merger and Creation of Biomerics Advanced Catheter Division 2MedExpress Quotes Late Summer, Early Fall As Best Time to Receive Flu Shot 2
... March 1, 2011 Heska Corporation (Nasdaq: ... and specialty products to veterinarians, today announced the addition ... in-clinic blood analyzers. (Logo:   http://photos.prnewswire.com/prnh/20000622/HESKALOGO ) ... analyzer is used to measure lactate, and is ideal ...
... successful contract packaging and re-packaging companies in the ... new, single-source industry leader called Aphena Pharma ... corporation based on a strategic alliance between Celeste ... Packaging; all long-term specialized leaders in the contract ...
Cached Medicine Technology:Heska Introduces New Lactate Meter Analyzer 2Merger of Four Pharmaceutical Companies Announced 2
... unique system uses prolene as thread-guide reducing ... The hollow Ritleng Probe is inserted into ... thread-guide is fed through it. The probe ... to pull the silicone tubing in place. ...
... For canalicular laceration or imperforate ... and Stainless Steel Probe. Box ... securely swaged into malleable stainless ... by punctum plug: no knots, ...
For Canalicular Stenosis. Non-traumatic tip. Silicone tubing swaged into probe. Note: Tubing securely swaged into malleable stainless steel probes. Medical grade silicone. Box of 3, sterile....
Recommended to insert plug portion of all monocanalicular intubation systems into punctum....
Medicine Products: